Actively Recruiting
Characterization, Treatment, and Long-term Follow-up of Fatigued Patients in Primary Care
Led by Karolinska Institutet · Updated on 2026-03-11
190
Participants Needed
1
Research Sites
412 weeks
Total Duration
On this page
Sponsors
K
Karolinska Institutet
Lead Sponsor
R
Region Stockholm
Collaborating Sponsor
AI-Summary
What this Trial Is About
The overarching purpose of this project is to further the understanding of fatigue as a symptom in primary care patients, and to build evidence for a highly accessible treatment targeting fatigue that can be readily implemented in primary care clinics. Data will be collected within a randomized controlled superiority trial. The primary aim is to evaluate the effectiveness of a transdiagnostic cognitive behavioral therapy (tCBT) for fatigued patients as compared to care as usual (CAU). Primary outcome will be change in fatigue severity (as measured by the Checklist Individual Strengths, fatigue subscale) pre- to post-treatment (6 months), with long-term controlled follow-up after 12 months. A register-based follow-up will be conducted up to 60 months post baseline. Moderators and mechanisms of treatment effect will be investigated with the aim to identify potential subgroups of fatigued individuals across and within diagnostic categories that may respond differently to treatment. Lastly, a health economic evaluation of long-term treatment effects will be conducted, which incorporates much needed detailed mapping of care as usual for fatigued patients.
CONDITIONS
Official Title
Characterization, Treatment, and Long-term Follow-up of Fatigued Patients in Primary Care
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 67 years
- Registered at a primary care clinic in Region Stockholm
- Severe, disabling fatigue present for at least 3 months
- Fatigue has a clear start and is not lifelong
- Fatigue not caused by active diseases requiring other treatments (e.g., thyroid issues, anemia, cancer, dementia) or medication side effects
- Regular access to a computer and internet
- Ability to read and write Swedish
- Ability to attend study visits up to 60 minutes and use internet materials
You will not qualify if you...
- Substance abuse disorder within the past 6 months
- Current or past psychosis or bipolar disorder
- Severe psychiatric disorders needing evidence-based treatment (e.g., OCD, moderate/severe depression, PTSD, anorexia nervosa)
- Elevated suicide risk
- Self-harm in past 6 months (e.g., cutting, burning, poisoning)
- Body mass index over 40
- Started or changed psychiatric medications in past month
- Ongoing chemotherapy
- Intellectual disability affecting treatment participation
- Pregnancy
- Life situations that prevent treatment (e.g., domestic violence, legal disputes, planned surgery, ongoing disability assessments)
- Receiving psychological treatment or multimodal rehabilitation currently
- Working night shifts
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Gustavsberg University Primary Care Clinic
Stockholm, Gustavsberg, Sweden, 134 40
Actively Recruiting
Research Team
F
Frank Svärdman, PhD-student
CONTACT
C
Conrad Samuelsson, PhD-student
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here